Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX)

CUSIP: 74006W207

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class
Equity / Common Stock, par value $0.0001 per share
Total 13F shares
18,424,832
Total 13F value
$762,133,327
Holder snapshot 6 visible 7 signals
Share change
+2,500,379
Put/Call ratio
93%
SEC-reported price per share
$41.36
Number of holders
113
Value change
+$67,529,667
Number of buys
79
Open additional details 1 more signal available
Number of sells
58
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,828,540

Security key

74006W207

Report period

Q2 2024

Institutions

113

Top holders

10

PRAX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 Praxis Precision Medicines, Inc. SEC filings Praxis Precision Medicines, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PRAX - Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAGE CAPITAL PARTNERS GP...
Disclosed value leader
ADAGE CAPITAL PARTNERS GP...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F Lead comparable stake: 5% Showing 1-6 of 15 holder rows.

Quick read

ADAGE CAPITAL PARTNERS GP, L.L.C. leads the comparable SEC ownership view at 5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAGE CAPITAL PARTNERS GP, L.L.C.'s linked filing trail.
Comparable ownership Top 5
ADAGE CAPITAL PARTNERS GP, L.L.C. 5%
Cormorant Asset Management, LP 4.7%
Point72 Asset Management, L.P. 3.4%
RA CAPITAL MANAGEMENT, L.P. 3%
PERCEPTIVE ADVISORS LLC 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
5%
$85,002,569
1,393,028 shares
 — 31 Mar 2024
Cormorant Asset Management, LP
13F
Company
13F
4.7%
$79,936,200
1,310,000 shares
 — 31 Mar 2024
Point72 Asset Management, L.P.
13F
Company
13F
3.4%
$58,221,623
954,140 shares
 — 31 Mar 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
3%
$50,547,748
828,380 shares
 — 31 Mar 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
3%
$50,133,361
821,589 shares
 — 31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
2.7%
$45,403,090
744,069 shares
 — 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
113
Shares
18,424,832
Rows available
113
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
110
Q2 2024 holders
113
Holder diff
3
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .